**Katee Sackhoff Marks Daughter’s Cancer Journey with Tattoos Celebrating Milestones**
:max_bytes(150000):strip_icc():format(jpeg)/katee-sackhoff-1-b8e0553995dd4ac4b590f96b9178e6b1.jpg)
Katee Sackhoff, best known for her role in the iconic film ‘Carrie’ and the hit series ‘The Mandalorian’, has opened up about the poignant journey she and her family have experienced following their daughter’s cancer diagnosis. Her daughter, Ginevra Grace “Ginny” Gadsby, was diagnosed with a rare form of cancer shortly after her birth. The actress and her husband, Robin Gadsby, recently shared their annual tradition of honouring their daughter’s milestones through a series of meaningful tattoos.
In an Instagram post shared on 22 October 2026, the 46-year-old actress expressed the sentimental value of these tattoos, stating that they serve as a permanent reminder of their love for Ginny. Each year, the couple has inked miniature tattoos representing Ginny’s favourite things, creating an evolving tribute that reflects her personality and interests. “When you have a child who’s been through everything ours has… you frakking celebrate! F**K Cancer!” Sackhoff passionately conveyed in her post, capturing the emotional weight behind their tattoos.
This touching family tradition appears to have begun five years ago, as Sackhoff detailed the symbols they have collected over the years, including images of a plane, a book, Ginny’s beloved monkey, and even a tribute to Wonder Woman. The couple’s first tattoo dedicated to their daughter was created in 2022, further solidifying their commitment to celebrating her life and experiences.
Sackhoff and Gadsby welcomed Ginny into their lives in December 2021 through surrogacy. In a heartfelt message shared at the time, Sackhoff expressed her joy and astonishment at how her family had grown, describing the overwhelming love she felt with the arrival of their daughter. The couple later expanded their family further with the arrival of their second child, Granger Oakes Gadsby, in 2024, also via surrogacy.
The challenging chapter of Ginny’s life began when she was just nine months old. During that time, her parents discovered a lump on her neck, leading to a biopsy that revealed the presence of a mass. Tragically, Ginny was diagnosed with neuroblastoma, a type of cancer that affects the nervous system in infants and young children. At just one year old, she underwent a rigorous treatment regime that included four rounds of chemotherapy aimed at shrinking the tumour.
As her treatment progressed, Ginny faced additional challenges when she had to undergo significant surgery to remove the regrown tumour. This procedure affected the nerves on the right side of her face, making her recovery all the more complicated. However, despite these harrowing experiences, Sackhoff revealed that in 2024, Ginny’s treatment was nearing its conclusion, and her immune system was reported to be strengthening.
By 2025, Sackhoff used her platform to raise awareness about the critical issue of paediatric cancer funding. Her posts highlighted Ginny’s remarkable progress, noting, “Our daughter is one of the lucky ones. She’s thriving now, off treatment but too many families don’t get the same outcome. That has to change.” Her advocacy work brings attention to the significant disparities in treatment outcomes faced by many families battling similar challenges.
The family’s ongoing journey serves not only as a testament to their resilience but also highlights the importance of supporting research and funding to improve outcomes for all children with cancer. As Sackhoff continues to share her experiences, she fosters a sense of community among those navigating similar paths.
Through their tattoos and social media presence, Sackhoff and Gadsby are dedicated to celebrating their daughter’s life while advocating for change in the world of paediatric health care. Their story reminds us of the strength of family bonds, the need for compassionate support through difficult times, and the vital importance of ongoing research and funding in the fight against childhood cancer.